about
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort studyFemale hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic diseaseNon-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?Potential utility of natural products as regulators of breast cancer-associated aromatase promotersThe influence of metabolic factors for nonalcoholic Fatty liver disease in women.Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.Causality assessment in drug-induced hepatotoxicity.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchEstrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance.Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice.SEURAT-1 liver gold reference compounds: a mechanism-based review.Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.The histopathological evaluation of drug-induced liver injury.Drug-induced Liver Injury: The Hepatic Pathologist's Approach.Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists.Cirrhosis with steatohepatitis following longterm stilboestrol treatment.Tamoxifen-induced cirrhotic process.Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.Sex differences in choline-deficient diet-induced steatohepatitis in mice.Role of Estrogens in the Regulation of Liver Lipid Metabolism.Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis.
P2860
Q33937093-E06DD7DA-4049-42D6-BA0E-C76529CD6FCAQ34252972-0BD11C7D-2766-4835-ACEE-390795A36B35Q34606036-7E8D6A7A-FC12-408C-9052-187190DD6956Q34677873-918EA4D8-6B61-42B1-B905-4F89429964E9Q34795935-9494E38D-488E-4722-9352-9E7E7A3A9C14Q35124690-40398F2D-6116-41B9-A984-43E37C678BF3Q35564120-0F7F96B6-E789-433E-92B7-4F0D3DC21F8CQ35681550-2636B2C6-27A3-4909-B8D9-657741805400Q35842573-5C69E8BB-93A9-4884-9EE1-5AEFA639B99FQ36129673-BC800EAC-31D7-4F15-97D2-5B81D330E10FQ36560629-FF05D650-214D-496F-8457-C7089A39F160Q37202331-E7297581-A493-47C4-8513-66D5AF199EFAQ38268013-857B3FEF-023E-4655-BCAD-F5A78BFB0AB0Q38687132-FA9CD16F-AAA1-49FE-968F-160AB37D3A17Q39037640-F19238F7-0FA8-4151-A2F3-DD7899DAAD09Q39307576-5B4F90C1-5B4B-43CA-9BA4-C508AD60325FQ42704420-C29DA271-2871-4FAD-BBCA-CD3A6C6C5152Q43011051-CEC12BEA-3A80-4BB1-BA30-ED90D946AC17Q43885641-548C1554-ED31-479A-AB43-94097B536B86Q44272187-638421D5-9D4E-4A87-BE3E-642198F13A72Q44735932-C73958E5-73FF-49B2-8403-578EF8E191C7Q47311531-85DFE161-DD90-4EFE-A416-8978F135474CQ48295306-C0C02943-2D22-4DFC-BDBB-9965D615EBAB
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@ast
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@en
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@nl
type
label
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@ast
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@en
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@nl
prefLabel
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@ast
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@en
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@nl
P2093
P921
P1433
P1476
Cirrhosis with steatohepatitis after adjuvant tamoxifen
@en
P2093
P356
10.1016/S0140-6736(05)74872-8
P407
P50
P577
1999-01-01T00:00:00Z